Lazanda FDA Approval History
FDA Approved: Yes (First approved June 30, 2011)
Brand name: Lazanda
Generic name: fentanyl
Dosage form: Nasal Spray
Previous Name: NasalFent
Company: Archimedes Pharma
Treatment for: Pain
Lazanda (fentanyl) is an opioid analgesic nasal spray for the management of breakthrough pain in cancer patients.
Development Timeline for Lazanda
|Jun 30, 2011||FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients|
|Sep 7, 2009||Archimedes Announces US Filing of NasalFent for the treatment of Breakthrough Cancer Pain|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.